Pharma Cos. Back Request For Justices To Eye Drug IP Case
Two pharmaceutical companies have urged the U.S. Supreme Court to take up an argument over obviousness in drug patent invalidations, telling the high court the Federal Circuit erred when it found...To view the full article, register now.
Already a subscriber? Click here to view full article